Title |
Vascular involvement in systemic sclerosis (scleroderma)
|
---|---|
Published in |
Journal of Inflammation Research, July 2011
|
DOI | 10.2147/jir.s18145 |
Pubmed ID | |
Authors |
Debendra Pattanaik, Monica Brown, Arnold E Postlethwaite |
Abstract |
Systemic sclerosis (SSc) is an acquired multiorgan connective tissue disease with variable mortality and morbidity dictated by clinical subset type. The etiology of the basic disease and pathogenesis of the systemic autoimmunity, fibrosis, and fibroproliferative vasculopathy are unknown and debated. In this review, the spectrum of vascular abnormalities and the options currently available to treat the vascular manifestations of SSc are discussed. Also discussed is how the hallmark pathologies (ie, how autoimmunity, vasculopathy, and fibrosis of the disease) might be effected and interconnected with modulatory input from lysophospholipids, sphingosine 1-phosphate, and lysophosphatidic acid. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 1% |
Egypt | 1 | 1% |
Unknown | 86 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 13 | 15% |
Student > Master | 11 | 13% |
Other | 10 | 11% |
Student > Ph. D. Student | 9 | 10% |
Researcher | 8 | 9% |
Other | 12 | 14% |
Unknown | 25 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 33 | 38% |
Agricultural and Biological Sciences | 10 | 11% |
Immunology and Microbiology | 7 | 8% |
Biochemistry, Genetics and Molecular Biology | 4 | 5% |
Engineering | 3 | 3% |
Other | 7 | 8% |
Unknown | 24 | 27% |